Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Sell
28,235
-456
-2% -$53.4K 1.16% 21
2026
Q1
$3.45M Sell
28,691
-704
-2% -$81.3K 1.24% 21
2025
Q4
$3.09M Sell
29,395
-1,586
-5% -$149K 1.07% 24
2025
Q3
$2.6M Buy
30,981
+239
+0.8% +$19.7K 0.94% 27
2025
Q2
$2.43M Buy
30,742
+2,291
+8% +$182K 0.96% 29
2025
Q1
$2.55M Buy
28,451
+2,698
+10% +$252K 1.1% 22
2024
Q4
$2.56M Buy
25,753
+2,381
+10% +$245K 1.01% 29
2024
Q3
$2.65M Buy
23,372
+933
+4% +$111K 1.07% 30
2024
Q2
$2.78M Sell
22,439
-129
-0.6% -$16.6K 1.13% 27
2024
Q1
$2.98M Sell
22,568
-78
-0.3% -$9.61K 1.21% 20
2023
Q4
$2.47M Sell
22,646
-113
-0.5% -$11.7K 1.04% 26
2023
Q3
$2.34M Sell
22,759
-222
-1% -$23.9K 1.08% 21
2023
Q2
$2.65M Sell
22,981
-31
-0.1% -$3.52K 1.23% 17
2023
Q1
$2.45M Sell
23,012
-113
-0.5% -$12.2K 1.21% 19
2022
Q4
$2.57M Sell
23,125
-69
-0.3% -$7.05K 1.4% 13
2022
Q3
$2M Hold
23,194
1.14% 21
2022
Q2
$2.12M Hold
23,194
1.18% 22
2022
Q1
$1.9M Buy
23,194
+1,548
+7% +$122K 0.87% 36
2021
Q4
$1.66M Buy
21,646
+862
+4% +$68.7K 0.65% 46
2021
Q3
$1.56M Buy
20,784
+2,805
+16% +$213K 0.64% 51
2021
Q2
$1.4M Buy
17,979
+2,166
+14% +$161K 0.6% 58
2021
Q1
$1.17M Buy
15,813
+1,660
+12% +$122K 0.5% 74
2020
Q4
$1.09M Buy
14,153
+5,794
+69% +$443K 0.51% 74
2020
Q3
$662K Buy
8,359
+53
+0.6% +$4.15K 0.39% 95
2020
Q2
$613K Buy
8,306
+4,944
+147% +$372K 0.37% 102
2020
Q1
$247K Buy
+3,362
New +$264K 0.2% 129

Other funds holding MRK

Malaga Cove Capital's MRK Position: Q2 2026 in Review

Malaga Cove Capital reduced its Merck (MRK) stake by 1.6% in Q2 2026, selling an estimated $53.4K and leaving 28,235 shares worth $3.63M. The position accounts for 1.16% of the portfolio, ranked #21.

Malaga Cove Capital first reported a position in MRK in Q1 2020 and has held it in 26 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Malaga Cove Capital held 28,235 shares of Merck worth $3.63M as of Q2 2026.
  • Malaga Cove Capital sold 456 Merck shares in Q2 2026, an estimated $53.4K.
  • Merck made up 1.16% of Malaga Cove Capital's portfolio in Q2 2026, its #21 holding.
  • Malaga Cove Capital first reported a position in Merck in Q1 2020 and has held it in 26 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.